President Bola Tinubu's directive banning the importation of certain medicines, including paracetamol, chloroquine, metronidazole, cotrimoxazole, aspirin, folic acid, multivitamin capsules, and ointments containing penicillin and gentamicin, has drawn mixed reactions from medical experts and policy analysts. The federal government's move shifts responsibility for supplying these drugs to domestic pharmaceutical manufacturers. Dr. Adedapo Adetoye, a medical doctor, described the decision as the right step, stating that the government had likely confirmed local production capacity for these specific drugs. He argued the policy could make drugs cheaper, reduce import dependence, and stimulate local manufacturing, citing India's self-reliance model as an aspirational example. Adetoye emphasized that citizen participation and long-term thinking are essential for national growth.
Dr. Titus Adejoorin expressed concern, noting Nigeria currently meets only 30 to 40% of its drug needs through local production. He warned the abrupt removal of imported alternatives could lead to shortages, price hikes, and increased morbidity and mortality. Adejoorin highlighted risks around weak regulatory oversight, stating that without stronger mechanisms at NAFDAC, the ban could create opportunities for counterfeit drugs and bribery. Sunday Charles Adeyemo supported the policy in principle, aligning with Health Minister Muhammad Ali Pate's push for medicine security, but cautioned that smuggling, price exploitation, substandard drugs, and infrastructure deficits could undermine its success.
The government claims local firms can meet demand for banned imports, yet experts confirm domestic production covers only 30 to 40% of national needs—exposing a gap between policy and reality. If supply falls short, Nigerians relying on paracetamol, chloroquine and folic acid may face shortages or turn to unregulated alternatives. Price surges and counterfeit drugs become more likely when enforcement and infrastructure lag behind executive directives. This policy risks becoming another top-down announcement without measurable safeguards for ordinary users.
💡 NaijaBuzz is an AI-assisted news aggregator. This content is curated from third-party sources — NaijaBuzz is not the original publisher and is not responsible for the accuracy of source reporting. The NaijaBuzz Take is AI-assisted editorial opinion only, not established fact. All persons mentioned are presumed innocent until proven guilty by a court of competent jurisdiction. NaijaBuzz does not endorse the views expressed in source articles.
